| From: Trumptown | 7/26/2024 5:01:40 PM | | | | | | PYRGF - Insider ownership high and he's buying more!
Those following along with PyroGenesis Canada Inc. ( TSE:PYR) will no doubt be intrigued by the recent purchase of shares by Photis Pascali, President of the company, who spent a stonking CA$1.2m on stock at an average price of CA$0.80. There's no denying a buy of that magnitude suggests conviction in a brighter future, although we do note that proportionally it only increased their holding by 2.0%.
finance.yahoo.com |
| | Pennies Arent Dead | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last ReadRead Replies (1) |
|
| From: Old Stock Collector | 8/22/2024 11:05:15 PM | | | | | | $AFFU updated website and the subsidiaries:
OneMind Technologies SL
Durham Black Inc
durham-black.com
Pink current
Just filed quarterly couple days ago.
Current price .0049 down from .02 high this year.
OneMind will be at a Nvidia event with Dell Technologies on November 5-7, 2024 at
Smart City Expo World Congress in Barcelona, Spain.
Nvidia / Dell / OneMind
Here is the link on Nvidia website:
nvidia.com
Click on Dell Technologies and this pops up for the Smart City Expo World Congress:
When: November 5-7 2024
Hall 1, C10
Featuring edge AI solutions with NVIDIA Jetson and Metropolis
Discover intelligent video analytics in action including demos in airports by Ipsotek, in stadiums & arenas by IntelexVision, and in public transport by AICUDA and Wobcom. Other demos cover city-as-a-service by Aveya Schneider, IOC & digital twin by Augment City and OneMind, plus Dell’s new NativeEdge operations software platform.
This is the 2nd year in a row for OneMind to be in the same booth with Dell & Nvidia |
| | Pennies Arent Dead | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Giants1967 | 9/6/2024 10:19:27 AM | | | | | | INTV Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market
Integrated Ventures Inc. (OTCQB: INTV), a holdings company, focused on e-commerce technology, digital assets and consumer-focused investments, is excited to announce (1) formation and launch of our second, fully funded, 100% owned subsidiary - MedWellDirect, LLC, Direct-To-Consumer (D2C) telemedicine solutions provider, mainly for weight loss and GLP-1 products and (2) acquisition of 51% stake in GetTrim.Com (TM), owned by Healthy Lifestyle USA – an innovative telemedicine weight loss services provider.
prnewswire.com |
| | Pennies Arent Dead | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Giants1967 | 9/13/2024 11:20:36 AM | | | | | | SSII SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline
globenewswire.com |
| | Pennies Arent Dead | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: getlouied | 9/17/2024 10:21:23 AM | | | | | | $CBDL CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness
https://www.accesswire.com/918828/cbd-life-sciences-inc-unveils-groundbreaking-nutritional-supplement-infused-with-mushroom-extracts-set-to-drive-revenue-and-revolutionize-wellness
Projected to increase company revenue by 20% in the first year, capitalizing on the booming $18 billion wellness market.
SCOTTSDALE, AZ / ACCESSWIRE / September 17, 2024 / CBD Life Sciences, Inc. (CBDL), an innovative leader in the CBD wellness industry, is set to launch a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system.
Recent studies highlight the effectiveness of reishi extract, not only in boosting the immune system but also in slowing or stopping tumor growth, a feature that positions this product as an essential addition to the wellness market. The blend of lion's mane extract and ashwagandha root provides additional cognitive support and anti-inflammatory benefits, making it an all-around solution for physical and mental well-being.
Unrivaled Benefits of Key Ingredients:
- Reishi Mushroom Extract: Renowned for its immune-boosting and anti-cancer properties, research suggests it can slow tumor growth, making it one of the most potent natural supplements available today.
- Lion's Mane Mushroom Extract: Known for supporting brain health, lion's mane helps to enhance cognitive function and promote nerve regeneration, ideal for those seeking long-term mental clarity.
- Ashwagandha Root Extract: Widely celebrated for reducing stress and its anti-inflammatory effects, ashwagandha contributes to overall mental health and physical recovery.
Revenue Projections & Market Potential
With the global supplement market experiencing rapid growth, the introduction of this new product is projected to significantly boost CBD Life Sciences, Inc.'s annual revenue. Analysts expect the market for mushroom-infused supplements to reach $18 billion by 2028, and with the unique blend of ingredients in this product, CBD Life Sciences, Inc. is poised to capture a substantial portion of that market. This launch is expected to drive a revenue increase of 20% within the first year, positioning the company at the forefront of the wellness supplement industry.
A Vision for the Future
Lisa Nelson, President and CEO of CBD Life Sciences, Inc., stated, "We are incredibly excited to bring this innovative product to the market. With the growing demand for natural, scientifically backed health solutions, we believe this supplement will be a game-changer, not only for our company but for the health-conscious consumers we serve." |
| | Pennies Arent Dead | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| |
